Biotechnology Research
San Francisco, California
2-10 employees
Founded 2018
About Alixia
Alixia is a biopharmaceutical company creating next-generation therapies for cancer, aging, and inflammatory diseases. It develops novel therapeutic compounds and provides collaborative research services to pharmaceutical partners and research institutions. The company's focus is on disrupting the tumor microenvironment to enable more effective treatments.
Company Classification
Customer Types
B2B
Business Models
ServicesLicensing
Product & Service Types
Oncology Therapeutics DevelopmentBiopharmaceutical Research ServicesScientific Advisory & Collaboration
Funding
Total Funding
$2.33M
No. of Funding Rounds
2
Customers
| Customer | Success Story | Source |
|---|---|---|
| Collaborated with Alixia on research exploring cancer, aging, and immunity intersections | ||
| Provided advisory expertise for tumor ecosystem research |
Sign up to Ethos to access the full customer list, plus detailed competitor and product analysis.
Sign up to Ethos